{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:14:40Z","timestamp":1788243280185,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00563-2","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:32:19Z","timestamp":1788240739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The growing need for heart failure specific risk prediction models and standardized care pathways in patients with cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Arianne Clare","family":"Agdamag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"1","key":"563_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","volume":"80","author":"R Florido","year":"2022","unstructured":"Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, et al. Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol. 2022;80(1):22\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"563_CR2","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","volume":"133","author":"RJ Koene","year":"2016","unstructured":"Koene RJ, Prizment AE, Blaes A, Konety SH. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016;133(11):1104\u201314.","journal-title":"Circulation"},{"key":"563_CR3","doi-asserted-by":"publisher","first-page":"1223660","DOI":"10.3389\/fcvm.2023.1223660","volume":"10","author":"I Bisceglia","year":"2023","unstructured":"Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, et al. Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals. Front Cardiovasc Med. 2023;10:1223660.","journal-title":"Front Cardiovasc Med"},{"key":"563_CR4","doi-asserted-by":"crossref","unstructured":"Sen J, Amir E, Austin P et al. Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations: JACC: CardioOncology State-of-the-Art Review. J Am Coll Cardiol CardioOnc. 2026 Apr;8(2):101\u201319.","DOI":"10.1016\/j.jaccao.2026.01.006"},{"issue":"1","key":"563_CR5","doi-asserted-by":"publisher","first-page":"2512645","DOI":"10.1080\/21645515.2025.2512645","volume":"21","author":"L Xu","year":"2025","unstructured":"Xu L, Chen Y, Xiong L, Shen Y, Zhou Z, Wang S, et al. A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers. Hum Vaccin Immunother. 2025;21(1):2512645.","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"563_CR6","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/ejhf.70005","volume":"27","author":"K Keramida","year":"2025","unstructured":"Keramida K, Lopez-Fernandez T, Anker MS, Petrie MC, Ameri P, Anderson LJ, et al. Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2025;27(11):2152\u201367.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"563_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cardfail.2024.08.045","volume":"31","author":"MW Bloom","year":"2025","unstructured":"Bloom MW, Vo JB, Rodgers JE, Ferrari AM, Nohria A, et al. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025;31(2):415\u201355. https:\/\/doi.org\/10.1016\/j.cardfail.2024.08.045.","journal-title":"J Card Fail"},{"issue":"12","key":"563_CR8","doi-asserted-by":"publisher","first-page":"e2546201","DOI":"10.1001\/jamanetworkopen.2025.46201","volume":"8","author":"C Xia","year":"2025","unstructured":"Xia C, Smith AM, Lefebvre B, Jamal FA, Armenian SH, Koropeckyj-Cox D, et al. Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial. JAMA Netw Open. 2025;8(12):e2546201.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"563_CR9","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"AR Lyon","year":"2020","unstructured":"Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945\u201360. https:\/\/doi.org\/10.1002\/ejhf.1920.","journal-title":"Eur J Heart Fail"},{"key":"563_CR10","doi-asserted-by":"crossref","unstructured":"Astarita A, Mingrone G, Airale L, Colomba A, Catarinella C, Cesareo MValidation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study. Cancers (Basel). 2025 Jul 15;17(14):2353.","DOI":"10.3390\/cancers17142353"},{"key":"563_CR11","doi-asserted-by":"crossref","unstructured":"Pons-Fuster E, Riquelme-Perez A, Shumbar V, Gonz\u00e1lez-Ponce CM, Fernandez-Avila JJ, Ram\u00f3n-Mart\u00ednez A et al. Validation and Exploratory Refinement of the HFA-ICOS Score for Cardiovascular Risk in Proteasome Inhibitor-Treated Multiple Myeloma: Single-Center Retrospective Study. Cancers. 2026;18(12):1924.","DOI":"10.3390\/cancers18121924"},{"issue":"1","key":"563_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clbc.2022.10.010","volume":"23","author":"X Liu","year":"2023","unstructured":"Liu X, Tao L, Wang M, Li H, Xu W. ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab. Clin Breast Cancer. 2023;23(1):23\u201331.","journal-title":"Clin Breast Cancer"},{"issue":"19","key":"563_CR13","doi-asserted-by":"publisher","first-page":"e029465","DOI":"10.1161\/JAHA.123.029465","volume":"12","author":"AF Yu","year":"2023","unstructured":"Yu AF, Lin IH, Jorgensen J, et al. Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. J Am Heart Assoc. 2023;12(19):e029465.","journal-title":"J Am Heart Assoc"},{"issue":"10 Pt 2","key":"563_CR14","doi-asserted-by":"publisher","first-page":"102129","DOI":"10.1016\/j.jacadv.2025.102129","volume":"4","author":"CH Soh","year":"2025","unstructured":"Soh CH, Nguyen L, Chu A, Salim A, Abdel-Qadir H, Marwick TH. Development of an Electronic Medical Record-Based Score for Heart Failure Prediction in Cancer Survivors. JACC Adv. 2025;4(10 Pt 2):102129. https:\/\/doi.org\/10.1016\/j.jacadv.2025.102129.","journal-title":"JACC Adv"},{"key":"563_CR15","doi-asserted-by":"publisher","unstructured":"Barac A, Chou J, Shara N, et al. Risk Prediction Model for Development of Heart Failure or Cardiomyopathy After Breast Cancer Treatment. JAMA Oncol Published online Oct. 2025;23. https:\/\/doi.org\/10.1001\/jamaoncol.2025.4178.","DOI":"10.1001\/jamaoncol.2025.4178"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00563-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:32:19Z","timestamp":1788240739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00563-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00563-2","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"109"}}